Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23811
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hergenç, Gülay | - |
dc.contributor.author | Budak, Yasemin | - |
dc.contributor.author | Taga, Yavuz | - |
dc.date.accessioned | 2022-01-03T08:55:25Z | - |
dc.date.available | 2022-01-03T08:55:25Z | - |
dc.date.issued | 1999-11 | - |
dc.identifier.citation | Hergenç, G. vd. (1999). "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls". Clinical Chemistry, 45(11), 2050-2050. | en_US |
dc.identifier.issn | 0009-9147 | - |
dc.identifier.uri | http://hdl.handle.net/11452/23811 | - |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Medical laboratory technology | en_US |
dc.title | Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000083440300055 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 2050 | tr_TR |
dc.identifier.endpage | 2050 | tr_TR |
dc.identifier.volume | 45 | tr_TR |
dc.identifier.issue | 11 | tr_TR |
dc.relation.journal | Clinical Chemistry | en_US |
dc.contributor.buuauthor | İlçöl, Yeşim | - |
dc.contributor.researcherid | AAL-8873-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.subject.wos | Medical laboratory technology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.wos.quartile | Q1 | en_US |
Appears in Collections: | Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.